Access Statistics for David Bardey

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Welfare Analysis of Genetic Testing in Health Insurance Markets with Adverse Selection and Prevention 0 0 2 26 0 0 3 9
A Welfare Analysis of Genetic Testing in Health Insurance Markets with Adverse Selection and Prevention 0 0 1 36 1 2 6 32
A paradoxical risk aversion effect on the consumers’ demand for quality 0 0 0 5 0 0 0 75
Adverse Selection vs Discrimination Risk with Genetic Testing. An Experimental Approach 0 0 0 50 0 0 0 127
Adverse Selection vs Discrimination Risk with Genetic Testing. An Experimental Approach 0 0 0 30 0 0 2 79
Análisis económico de la normativa de libre competencia en Colombia 0 0 1 19 0 0 2 87
Characterization of the relevant market in the media industry: some new evidence! 0 0 1 71 0 0 5 73
Competencia en el sector de la salud: énfasis en el caso colombiano 0 1 3 63 0 1 7 192
Competition among health plans: a two-sided market approach 0 0 1 292 0 3 13 780
Competition between Managed Care Organizations and Indemnity Plans in Health Insurance Markets 0 0 1 101 0 3 9 109
Competition in Health Care Markets and Vertical Restraints 0 0 0 173 0 0 1 542
Competition in Health Care Markets and Vertical Restraints 0 0 0 52 1 1 2 222
Competition in two-sided markets with common network externalities 0 0 1 212 0 0 2 437
Competition in two-sided markets with common network externalities 0 0 0 167 0 0 0 466
Competition in two-sided markets with common network externalities 0 0 0 166 1 1 1 240
Concentration of the Mobile Telecommunications Markets and Countries' Competitiveness 1 1 9 81 2 2 21 236
Controlling Sellers Who Provide Advice: Regulation and Competition 0 0 0 53 0 0 0 145
Controlling Sellers Who Provide Advice: Regulation and Competition* 0 0 0 0 0 0 0 14
Controlling Sellers Who Provide Advice: Regulation and Competition* 0 0 0 0 0 0 0 10
Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at Least) in the Short Run? 0 0 0 11 0 0 0 23
Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run? 0 0 1 15 0 0 4 46
Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run? 0 0 0 11 0 0 0 39
Doctors' remuneration schemes and hospital competition in two-sided markets with common network externalities 0 0 0 60 1 4 7 112
Doctors' remuneration schemes and hospital competition in two-sided markets with common network externalities 0 0 0 74 0 1 1 148
Doctors´ remuneration schemes and hospital competition in two-sided markets with common network externalities 0 0 0 129 0 0 2 251
Drugs, Showrooms and Financial Products: Competition and Regulation When Sellers Provide Expert Advice 0 0 0 15 0 0 0 45
Drugs, Showrooms and Financial Products: Competition and Regulation When Sellers Provide Expert Advice 0 0 0 0 2 2 2 16
Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 0 0 0 41 0 0 2 49
Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 0 0 3 28 0 0 3 109
Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 0 0 0 26 0 0 0 7
Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 0 0 0 37 0 0 0 60
Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review 0 0 0 0 3 3 6 6
Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review 0 0 6 6 3 3 11 11
Economic Incentives to Develop and to Use Diagnostic Tests a Literature Review 0 0 19 19 1 1 25 25
El trabajo intermediado por plataformas en Colombia: aspectos conceptuales y propuesta de regulación desde la teoría de contratos y la organización industrial 0 0 1 9 0 0 3 12
Genetic testing with primary prevention and moral hazard 0 0 0 19 0 0 0 82
Genetic testing with primary prevention and moral hazard 0 0 0 48 1 3 5 202
Genetic testing with primary prevention and moral hazard 0 0 0 28 0 0 2 98
Genetic testing with primary prevention and moral hazard 0 0 0 14 1 1 2 79
Genetic testing with primary prevention and moral hazard 0 0 0 14 0 0 0 73
Healt care network formation and policyholders'welfare 0 0 1 31 0 0 3 161
Health Care Insurance Payment Policy when the Physician and Patient May Collude 0 0 0 20 0 0 1 63
Health Care Insurance Payment Policy when the Physician and Patient May Collude 0 1 1 10 0 1 1 93
Health Care Network Formation and Policyholders' Welfare 0 0 0 48 0 0 1 136
Health Care Providers Payments Regulation when Horizontal and Vertical Differentiation Matter 0 0 0 57 0 0 0 201
Health Care Providers Payments Regulation when Horizontal and Vertical Differentiation Matter 0 0 0 133 0 0 0 425
Health Insurance and Diversity of Treatment: A Policy Mix Perspective 0 0 0 36 0 0 0 117
Health care insurance payment policy when the provider and patient May Collude 0 0 0 0 0 1 1 4
Health insurance and diversity of treatment: a policy mix perspective 0 0 0 28 0 2 2 83
How Is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment 0 0 0 35 0 0 1 121
How Is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing?: Theory and Experiment 1 1 1 59 2 2 3 68
How is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment 0 0 0 63 1 1 3 81
Incentivizing Physicians' Diagnostic Effort and Test with Moral Hazard and Adverse Selection 3 4 4 4 1 6 6 6
Incentivizing Physicians' Diagnostic Effort and Test with Moral Hazard and Adverse Selection 0 3 3 3 0 10 10 10
Informality and Optimal Public Policy 0 0 1 36 0 0 1 47
Informality and Optimal Public Policy 0 0 0 42 0 2 2 149
Informality and optimal public policy 0 0 0 0 0 0 1 1
Integración vertical en el sector de la salud colombiano 0 0 2 58 0 0 4 160
La economía de los mercados de dos lados: aplicación al análisis de las tarjetas de pago en Colombia 0 1 4 205 0 3 9 852
Nursing Homes' Competition and Distributional Implications when the Market is Two-Sided 0 0 0 34 0 0 0 61
Nursing Homes’ Competition and Distributional Implications when the Market is Two-Sided 0 0 1 15 0 0 4 70
Nursing homes' competition and distributional implications when the market is two-sided 0 0 0 7 0 0 2 15
Physicians' Incentives to Adopt Personalized Medicine: Experimental Evidence 0 0 0 42 0 0 0 37
Physicians’ Incentives to Adopt Personalized Medicine: Experimental Evidence 0 0 0 9 1 1 2 30
Physicians’ incentives to adopt personalised medicine: Experimental evidence 0 0 0 9 0 0 0 15
Physicians’ incentives to adopt personalized medicine: experimental evidence 0 0 0 45 0 2 2 41
Physicians’ incentives to adopt personalized medicine: experimental evidence 0 0 0 6 0 1 3 53
Precios máximos de venta en el mercado de medicamentos colombiano: una evaluación de impacto 0 0 1 30 0 0 4 107
Price cap regulation in the Colombian pharmaceutical market: An impact evaluation 0 0 1 10 0 0 1 30
Price cap regulation in the Colombian pharmaceutical market: An impact evaluation 0 1 4 13 0 1 6 49
Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry 0 0 0 85 0 0 2 301
Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry 0 0 1 309 0 0 6 864
Seguros de desempleo: revisión de literatura y propuesta para Colombia 0 0 1 205 0 0 3 866
Small-area variation in health care affecting the choice of cesarean delivery: the case of a colombian health insurer 0 0 0 81 0 0 2 409
Supplementary health insurance in the Colombian managed care system: Adverse or advantageous selection? 0 0 0 33 0 0 0 46
Supplementary health insurance in the Colombian managed care system: ¿Adverse or advantageous selection? 0 0 0 12 0 1 4 61
Teoría del control óptimo: ¡Una guía para principiantes! 0 0 7 1,167 1 1 16 3,848
Teorías y algunas experiencias internacionales en el financiamiento de la educación superior: lecciones para Colombia 0 1 2 184 0 5 9 1,192
The Design of Insurance Coverage for Medical Products under Imperfect Competition 0 0 0 7 0 0 0 74
The Design of Insurance Coverage for Medical Products under Imperfect Competition 0 0 0 19 0 0 0 75
The Health Technology Assessment Approach of The Economic Value of Diagnostic Test: A Literature Review 0 0 15 15 1 1 19 19
The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests - A Literature Review 0 0 3 3 4 4 9 9
The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests - A Literature Review 1 1 2 2 2 2 8 8
The design of insurance coverage for medical products under imperfect competition 0 0 0 9 0 0 0 75
The design of insurance coverage for medical products under imperfect competition 0 0 0 22 0 0 0 77
The regulation of health care providers' payments when horizontal and vertical differentiation matter 0 0 0 2 0 0 0 46
Unemployment Insurance in the Presence of an Informal Sector 1 1 3 84 1 1 5 204
Unemployment insurance and informality in developing countries 0 0 1 76 0 0 1 149
Unemployment insurance and informality in developing countries 0 0 5 113 0 3 17 333
Unemployment insurance in the presence of an informal 0 0 0 43 0 0 2 136
Unemployment insurance/severance payments and informality in developing countries 0 0 1 23 0 0 1 112
Voluntary Health Plan Subsidies and Public Expenditure 0 0 0 5 0 1 3 53
Voluntary Health Plan Subsidies and Public Expenditure 0 0 0 19 0 1 1 67
Voluntary Health Plan Subsidies and Public Expenditure 0 0 0 16 0 1 1 77
Welfare Impacts of Genetic Testing in Health Insurance Markets: Will Cross-Subsidies Survive? 0 0 0 4 0 1 5 45
¿Tiene efectos negativos el TLC sobre los precios de los medicamentos y la salud de los colombianos? 0 0 0 145 0 0 2 1,098
Total Working Papers 7 16 115 5,972 31 86 338 18,898


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A paradoxical risk aversion effect on the consumers' demand for quality 0 0 0 13 0 0 2 73
Competencia en el sector de la salud: énfasis en el caso colombiano 0 2 2 16 0 2 3 91
Competition Among Health Plans: A Two‐Sided Market Approach 0 0 2 87 0 0 2 255
Competition between health maintenance organizations and nonintegrated health insurance companies in health insurance markets 0 0 0 4 0 0 1 51
Competition in Two-Sided Markets with Common Network Externalities 0 0 0 35 0 0 1 107
Concentration of the mobile telecommunications markets and countries’ competitiveness 0 1 6 13 1 4 26 51
Contrat d'assurance maladie optimal et risque moral ex ante. Quand peut-on s'affranchir d'une franchise ? 0 0 0 13 0 0 0 99
Controlling Sellers Who Provide Advice: Regulation and Competition 0 0 0 9 0 0 0 38
Demande induite et réglementation de médecins altruistes 0 0 0 7 0 0 0 69
Demande induite et réglementation de médecins altruistes 0 0 0 6 0 0 0 91
Doctors' Remuneration Schemes and Hospital Competition in a Two-Sided Market 1 1 1 23 1 2 5 109
Efficacité et risque moral ex post en assurance maladie 0 0 2 20 0 1 3 117
Estimation de l'efficience des dépenses de santé au niveau départemental par la méthode DEA 0 0 0 9 0 0 2 29
Estimation de l’efficience des dépenses de santé au niveau départemental par la méthode DEA 0 0 0 7 0 0 0 27
Genetic testing with primary prevention and moral hazard 0 0 0 17 0 0 2 105
Gestion des risques longs et comportements de risque moral sur les marchés d'assurance maladie la première inefficacité peut-elle éliminer la seconde ? 0 0 0 5 0 0 0 24
Health Care Network Formation and Policyholders' Welfare 0 0 0 29 0 1 3 133
Health care insurance policies When the provider and patient may collude 0 0 1 18 0 0 6 64
Health insurance and diversity of treatment 0 0 0 30 0 0 0 92
How is the trade-off between adverse selection and discrimination risk affected by genetic testing? Theory and experiment 0 0 0 8 0 0 2 51
Informality and Optimal Public Policy 0 0 2 18 0 0 5 52
Integración vertical en el sector colombiano de la salud 0 1 2 16 1 2 4 57
La regulación de tarifas en el sector de la salud en Colombia 0 0 1 53 0 0 1 216
Médecine personnalisée, tests génétiques et assurance santé: une tension exacerbée entre antisélection et discrimination des risques 0 0 0 7 2 6 6 37
Nursing‐homes' competition and distributional implications when the market is two‐sided 0 0 0 3 0 1 2 13
Optimal health insurance contract: Is a deductible useful? 0 0 0 145 0 0 0 424
Optimal regulation of health system with induced demand and 'ex post' moral hazard 0 0 1 25 1 1 6 70
Physicians’ incentives to adopt personalised medicine: Experimental evidence 0 0 1 4 0 1 5 26
Retail price regulation and innovation: Reference pricing in the pharmaceutical industry 0 0 2 84 0 0 3 372
Supplemental health insurance in the Colombian managed care system: Adverse or advantageous selection? 0 0 1 17 0 3 4 78
The design of insurance coverage for medical products under imperfect competition 0 0 1 30 0 0 1 156
The regulation of health care providers’ payments when horizontal and vertical differentiation matter 0 0 1 47 0 0 3 161
Unemployment Insurance in the Presence of an Informal Sector 0 0 0 23 0 0 0 79
Total Journal Articles 1 5 26 841 6 24 98 3,417


Statistics updated 2025-02-05